参考文献/References:
[1] Myers KJ,Dean NM.Sensible use of antisense:how to use oligonucleotides as research tools[J].Trends Phimacol Sci,2000,21:19-23.
[2] Poston RS,Tran KP,Mann M J,et al.Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotide[J].J Heart Lung Transplant,1998,17:349-355.
[3] Hnatowich DJ.Changing focus:applying antisense to nuclear medicine imaging[J].Mol Med Today,1999,5:151.
[4] ManiS,Gu Y,Wadler S,et al.Antisense therapeutics in oncology:points to consider in their clinical evaluation[J].Antisense Nucleic Acid Drug Dev,1999,9:543-547.
[5] Asaoka K,Tadam,Sawamura Y,et al.Dependence of efficient adenviral gene delivery in malignant glioma cells on the expression levels of the coxsackievirus and adenovirus recepter[J].J Neursurg,2000,92:1002-1008.
[6] Malatynska E,Matheson GK,Goldenberg R,et al.Effects of treatment with GABA(A) receptor subunit antisense oligodeoxynucleotides on GABA-stimulated 36C1-infiux in the rat cerebral cortex[J].Neurochem Int,2000,36:45-54.
[7] Cooper SR,Taylor JK,Miraglia LJ,et al.Pharmacology of antisense oligonucleotide inhiibitors of protein expression[J].Pharmacol Ther,1999,82.427-435.
[8] Hogrefe RI.An antisense oligonucleotide primer[J].Antisense Nucleic Acid Drug Dev,1999,9:351-357.
[9] Gauchez AS,Du Moulinet D’Hardemare A,Lunardi J,et al.Potential use of radiolabeled antisense oligonucleotides in oncology[J].Anticancer Res,1999,19:4989-4997.
[10] Alt M,Eisenhardt S,Serwe M,et al.Comparative inhibitory potential of diffently modified antisense oligodeoxynucleotides on hepatitis C virus translation[J].Eur J Clin Invest.1999,29:868-876.
[11] Hnatowich DJ.Antisense and nuclear medicine[J].J Nucl Med,1999,40(4):693-703.
[12] Tavitian B.In vivo antisense imaging[J].Q J Nucl Med,2000,44:236-255.
[13] Dewanjee MK,Vargas R,Ghafouripour AK,et al.Kinetics of intracellular hybridization of c-myc mRNA oncogene with 111In labeled antisense deoxyoligonucleotide probes in leukemic cells[J].J Nucl Med,1994,34:224.
[14] Lu Xiao-ming,Alan J,Fischman,et al.Antisense DNA delivery in vivo:Liver targeting by receptor-mediated uptake[J].J Nucl Med,1994,35:269-275.
[15] Dewanjee M K,Ghafouripour AK,Kapadvanjwala M,et al.Radiolabeled antisense oligodeoxynucleotides:in vitro and in vivo applications[J].JClin Immunoassay,1993,16:276-289.
[16] HnatowichDJ,Winnard P,Virzi F,et al.Technetium-99m labeling of DN A oligonucleotides[J].J Nud Mecl,1995,36:2306-2314.
[17] Hnatowich DJ.Antisense imaging:Where are we now?[J].Cancer Biother Radiopharm,2000,15:447-457.
相似文献/References:
[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[3]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[4]杨洋,樊赛军.LXXLL模体在雌激素受体信号通路中的作用及应用价值[J].国际放射医学核医学杂志,2014,38(1):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
Yang Yang,Fan Saijun.Role of LXXLL motif in modulation of estrogen receptor signaling and its potential application[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
[5]白庆双,李宁,方佩华,等.人血清TRAb酶联免疫吸附试验检测在甲状腺疾病患者中的临床应用[J].国际放射医学核医学杂志,2014,38(2):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
Bai Qingshuang,Li Ning,Fang Peihua,et al.The clinical application of human serum level of the TRAb measured by enzyme-linked immunosorbent assay in patients with thyroid diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
[6]李丽,赵长久,田国梅.CXC型趋化因子受体4及其分子显像剂在肿瘤方面的研究进展[J].国际放射医学核医学杂志,2014,38(3):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
Li Li,Zhao Changjiu,Tian Guomei.Research progress of CXC chemokine receptor type 4 and molecular imaging in tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
[7]周晓靓,王浩,施培基,等.表皮生长因子受体-酪氨酸激酶肿瘤分子显像剂的研究进展[J].国际放射医学核医学杂志,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
ZHOU Xiao-liang,WANG Hao,SHI Pei-ji,et al.The developme nt of epidermal growth factor receptor molecular imaging in cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
[8]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[9]袁杰,刘兴党,韩梅.SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用[J].国际放射医学核医学杂志,2013,37(1):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
YUAN Jie,LIU Xing-dang,HAN Mei.Neuroreceptor and its transporters imaging by PET and SPECT in heroin addiction[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
[10]鲍伟奇,邱春,管一晖.γ-氨基丁酸A型-苯二氮革受体显像剂在神经系统疾病中的应用[J].国际放射医学核医学杂志,2012,36(1):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]
BAO Wei-qi,QIU Chun,GUAN Yi-hui.Application of gamma-aminobutyric acid type A-benzodiazepine receptor imaging for study of neuropsychiatric disorders[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]